Revised Q2 FY27 investor presentation fixes page 12 typo errors
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tatva Chintan revised its Q2 FY27 investor presentation to fix typographical errors on page 12. Corrected numbers: H1FY27 RoE is 6.3 percent (not 2.6 percent), and Debt to EBITDA is 1.16x annualized (not 4.30). Other figures unchanged. Q2 FY27 revenue hit a record Rs 2,173 Mn, up 76 percent YoY. H1 EBITDA margin held at 19 percent despite temporary pressure from a 60 to 100 percent rise in solvent prices and over 100 percent jump in global freight. Management guides margins to normalise in Q3 FY27.
Corrections improve H1 FY27 RoE optics and lower leverage profile; business momentum strong, with margin recovery guided for Q3 FY27.